Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.65 |
| ▸ | TOP2A | P11388 | 3/20 | 0.60 |
| ▸ | CES2 | O00748 | 1/20 | 0.60 |
| ▸ | CES1 | P23141 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.51 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.51 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.51 |
| ▸ | USP7 | Q93009 | 1/20 | 0.51 |
| ▸ | RORC | P51449 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18100185 | 1.00 | PTPN1 (0.65) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL14350531 | 1.00 | PTPN1 (0.65) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL12640552 | 0.86 | PTPN1 (0.61) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL6573661 | 0.85 | PTPN1 (0.58) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL1721265 | 0.83 | PTPN1 (0.58) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL422274 | 0.83 | PTPN1 (0.57) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL13359971 | 0.82 | PTPN1 (0.60) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL18688190 | 0.82 | PTPN1 (0.60) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL18690037 | 0.82 | PTPN1 (0.60) | PTPN1TOP2ACES2CES1USP2 | |
| SCHEMBL423196 | 0.81 | PTPN1 (0.55) | PTPN1TOP2ACES2CES1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024223186-A1 | PREPARATIONS COMPRISING OLEANOL GLYCOSIDES | ANALYTICON DISCOVERY GMBH (DE) | 2024-10-31 | — | — | WO | claimed |
| EP-4454482-A1 | PREPARATIONS COMPRISING OLEANOL GLYCOSIDES | Analyticon Discovery GmbH (DE) | 2024-10-30 | — | — | EP | claimed |
| WO-2023109881-A1 | HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER | 华中师范大学 | 2023-06-22 | — | — | WO | claimed |
| CN-115989035-A | ACTRII proteins for the treatment of Pulmonary Arterial Hypertension (PAH) | 阿塞勒隆制药公司 | 2023-04-18 | — | — | CN | claimed |
| EP-3262067-B1 | NEW DODECAPEPTIDES AND MICROCAPSULES FUNCTIONALISED WITH THEM TARGETED TO FIBROBLASTS | INFINITEC ACTIVOS S L (ES) | 2019-02-06 | — | — | EP | claimed |
| US-20180258140-A1 | NEW DODECAPEPTIDES AND MICROCAPSULES FUNCTIONALISED WITH THEM TARGETED TO FIBROBLASTS | PEPTIDEPHARMA NOVA, S.L. (ES) | 2018-09-13 | — | — | US | claimed |
| EP-3262067-A1 | NEW DODECAPEPTIDES AND MICROCAPSULES FUNCTIONALISED WITH THEM TARGETED TO FIBROBLASTS | Infinitec Activos S.L. (ES) | 2018-01-03 | — | — | EP | claimed |
| WO-2016135203-A1 | NEW DODECAPEPTIDES AND MICROCAPSULES FUNCTIONALISED WITH THEM TARGETED TO FIBROBLASTS | INFINITEC ACTIVOS, S.L. (ES) | 2016-09-01 | — | — | WO | claimed |
| EP-3061767-A1 | New dodecapeptides and microcapsules functionalised with them targeted to fibroblasts | Infinitec Activos, S.L. (ES) | 2016-08-31 | — | — | EP | claimed |
| EP-2241306-A2 | Compound with antioxidant peptides | Henkel AG & Co. KGaA (DE) | 2010-10-20 | — | — | EP | claimed |
| EP-1790330-A2 | Cosmetic and dermatological compositions containing oligopeptides and apple extract | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-05-30 | — | — | EP | claimed |
| EP-1776087-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-04-25 | — | — | EP | claimed |
| EP-1640041-A2 | Cosmetic and dermatological composition for the treatment of aging or photodamaged skin | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-29 | — | — | EP | claimed |
| EP-1634576-A1 | DNA repair enzymes and oligopeptides containing cosmetic and dermatological compositions | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-03-15 | — | — | EP | claimed |
| WO-2006018198-A1 | COSMETIC AND DERMATOLOGICAL COMPOSITIONS COMPRISING (2-HYDROXYETHYL)UREA | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | WO | claimed |
| EP-1272154-B1 | COMPOSITION FOR IMPROVING SKIN LIPID BARRIER FUNCTION | COLOR ACCESS INC (US) | 2004-09-22 | — | — | EP | claimed |
| EP-1272154-A1 | COMPOSITION FOR IMPROVING SKIN LIPID BARRIER FUNCTION | Color Access, Inc. (US) | 2003-01-08 | — | — | EP | claimed |
| WO-2001074327-A1 | COMPOSITION FOR IMPROVING SKIN LIPID BARRIER FUNCTION | COLOR ACCESS, INC. (US) | 2001-10-11 | — | — | WO | claimed |
| CN-1307473-A | Triterpene compositions and methods of their use | RES DEV FOUDATION (US) | 2001-08-08 | — | — | CN | claimed |
| US-4789752-A | REACTING HALIDES WITH ALCOHOLS IN SOLVENT, ADDING ACID ACCEPTORS | HUELS TROISDORF AKTIENGESELLSCHAFT (DE) | 1988-12-06 | — | — | US | claimed |